These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22219194)

  • 21. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.
    Battle S; Gogonea V; Willard B; Wang Z; Fu X; Huang Y; Graham LM; Cameron SJ; DiDonato JA; Crabb JW; Hazen SL
    J Biol Chem; 2022 Apr; 298(4):101832. PubMed ID: 35304099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of anti-chloro
    Lokeshwaran K; Hemadou A; Jayaprakash NS; Prasanna RR; Jacobin-Valat MJ; Dieryck W; Joucla G; Vijayalakshmi MA; Clofent-Sanchez G; Santarelli X; Venkataraman K
    J Immunol Methods; 2019 Nov; 474():112637. PubMed ID: 31386835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species.
    Pennathur S; Bergt C; Shao B; Byun J; Kassim SY; Singh P; Green PS; McDonald TO; Brunzell J; Chait A; Oram JF; O'brien K; Geary RL; Heinecke JW
    J Biol Chem; 2004 Oct; 279(41):42977-83. PubMed ID: 15292228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
    Malle E; Marsche G; Panzenboeck U; Sattler W
    Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
    Gao D; Podrez EA
    Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.
    Smith CK; Vivekanandan-Giri A; Tang C; Knight JS; Mathew A; Padilla RL; Gillespie BW; Carmona-Rivera C; Liu X; Subramanian V; Hasni S; Thompson PR; Heinecke JW; Saran R; Pennathur S; Kaplan MJ
    Arthritis Rheumatol; 2014 Sep; 66(9):2532-2544. PubMed ID: 24838349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using adenovirus-mediated gene transfer to study the effect of myeloperoxidase on plasma lipid levels, HDL structure and functionality in mice expressing human apoA-I forms.
    Dalakoura-Karagkouni K; Tiniakou I; Zannis VI; Kardassis D
    Biochem Biophys Res Commun; 2022 Sep; 622():108-114. PubMed ID: 35843089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
    Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
    J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
    Hazen SL; Heinecke JW
    J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein.
    Bergt C; Fu X; Huq NP; Kao J; Heinecke JW
    J Biol Chem; 2004 Feb; 279(9):7856-66. PubMed ID: 14660678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of myeloperoxidase oxidation and
    Kameda T; Horiuchi Y; Shimano S; Yano K; Lai SJ; Ichimura N; Tohda S; Kurihara Y; Tozuka M; Ohkawa R
    Biol Chem; 2022 Feb; 403(3):265-277. PubMed ID: 34448387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice.
    Parastatidis I; Thomson L; Fries DM; Moore RE; Tohyama J; Fu X; Hazen SL; Heijnen HF; Dennehy MK; Liebler DC; Rader DJ; Ischiropoulos H
    Circ Res; 2007 Aug; 101(4):368-76. PubMed ID: 17615369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of novel truncated apolipoprotein A-I in human high-density lipoprotein generated by sequential treatment with myeloperoxidase and chymase.
    Lai SJ; Kameda T; Morita M; Yamagata Y; Nishizaka K; Horiuchi Y; Kobayashi Y; Usami Y; Liu JJ; Kasama T; Tozuka M; Ohkawa R
    Biochimie; 2024 Mar; 218():34-45. PubMed ID: 37774825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.
    Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G
    FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.
    Undurti A; Huang Y; Lupica JA; Smith JD; DiDonato JA; Hazen SL
    J Biol Chem; 2009 Nov; 284(45):30825-35. PubMed ID: 19726691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity.
    Dinnes DL; White MY; Kockx M; Traini M; Hsieh V; Kim MJ; Hou L; Jessup W; Rye KA; Thaysen-Andersen M; Cordwell SJ; Kritharides L
    FASEB J; 2016 Dec; 30(12):4239-4255. PubMed ID: 27630170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans.
    Vaisar T; Shao B; Green PS; Oda MN; Oram JF; Heinecke JW
    Curr Atheroscler Rep; 2007 Nov; 9(5):417-24. PubMed ID: 18001626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I.
    Hossain MA; Ngeth S; Chan T; Oda MN; Francis GA
    BMC Biochem; 2012 Jan; 13():1. PubMed ID: 22248050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.